D2 Lymphadenectomy for Gastric Cancer: Advancements and Technical Considerations

Ahmed Dehal1, Yanghee Woo2, Evan S Glazer3

  • 1Department of General Surgery, Southern California Permanente Medical Group, Department of Clinical Sciences, Kaiser Permanente School of Medicine, Los Angeles, CA, USA. ahmed.n.dehal@kp.org.

Annals of Surgical Oncology
|November 26, 2024
PubMed
Summary

D2 lymphadenectomy (LND) is the standard surgical treatment for locally advanced gastric cancer (GC), offering survival benefits. This review covers D2 LND techniques, controversies, and the role of ICG fluorescence imaging for improved lymph node identification.

Related Concept Videos